secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001213900-24-093514
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics receives Nasdaq deficiency notice for minimum bid price non-compliance
--------------------------------------------------------------------------------

- Nasdaq notified HOTH on Oct 30, 2024 that common stock failed minimum $1.00 bid price for 30 consecutive business days.
- Common stock continues trading on Nasdaq Capital Market under HOTH; no immediate effect on listing.
- Company has 180 days, until April 28, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by April 28, 2025, an additional 180-day period may be granted if other listing requirements are met.
- Company may consider implementing a reverse stock split to cure the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024093514/0001213900-24-093514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024093514/ea0219197-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-093514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer